Thou Shalt Not Pass? How to Navigate the Latest Policies on Cross-Border Data Flow

Join a distinguished panel of international data privacy & data security experts for the latest challenges impacting multi-country clinical trials and how to navigate them. Drug developers, hospitals, and CROs conducting MRCTs are subject to stringent national and international cross-border data regulations that apply to the collection, use, retention, protection, and cross-border transfer of clinical data. Just in October 2022, the Biden Administration issued an Executive Order on the EU-US Data Privacy Framework and in September 22, another Executive Order on Biomanufacturing also called for a Data for the Bioeconomy Initiative. The question remains, will they help spur life-sciences innovation by facilitating effective global clinical trials, or hinder them?

The panel will examine the latest regulations on clinical data privacy, security, and transfer in key markets including China and EU. The panel will also discuss emerging trends and efforts to advocate for a Trans-Atlantic Data Privacy Framework.